The effect of tumor subtype on survival and the graded prognostic assessment (GPA) for patients with breast cancer and brain metastases.

被引:2
|
作者
Sperduto, P. W.
Kased, N.
Roberge, D.
Shanley, R.
Chao, S. T.
Bhatt, A. K.
Brown, P. D.
Shih, H. A.
Kirkpatrick, J.
Gaspar, L. E.
机构
[1] Univ Minnesota, Gamma Knife Ctr, Waconia, MN USA
[2] Minneapolis Radiat Oncol, Waconia, MN USA
[3] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA
[4] McGill Univ, Dept Radiat Oncol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada
[5] Univ Minnesota, Minneapolis, MN USA
[6] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[7] Univ Wisconsin Hosp, Dept Radiat Oncol, Madison, WI USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[9] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[10] Duke Univ, Med Ctr, Durham, NC USA
[11] Univ Colorado Denver, Aurora, CO USA
关键词
D O I
10.1200/jco.2011.29.27_suppl.238
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
238
引用
收藏
页数:1
相关论文
共 50 条
  • [31] The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
    Sperduto, Paul W.
    Kased, Norbert
    Roberge, David
    Chao, Samuel T.
    Shanley, Ryan
    Luo, Xianghua
    Sneed, Penny K.
    Suh, John
    Weil, Robert J.
    Jensen, Ashley W.
    Brown, Paul D.
    Shih, Helen A.
    Kirkpatrick, John
    Gaspar, Laurie E.
    Fiveash, John B.
    Chiang, Veronica
    Knisely, Jonathan P. S.
    Sperduto, Christina Maria
    Lin, Nancy
    Mehta, Minesh
    JOURNAL OF NEURO-ONCOLOGY, 2013, 112 (03) : 467 - 472
  • [32] Radiotherapy of brain metastases according to the GPA score (Graded Prognostic Assessment)
    Antoni, D.
    Noel, G.
    CANCER RADIOTHERAPIE, 2013, 17 (5-6): : 424 - 427
  • [33] CNS metastases in breast cancer patients: prognostic implications of tumor subtype
    Bachmann, C.
    Schmidt, S.
    Staebler, A.
    Fehm, T.
    Fend, F.
    Schittenhelm, J.
    Wallwiener, D.
    Grischke, E.
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 6
  • [34] CNS metastases in breast cancer patients: prognostic implications of tumor subtype
    C. Bachmann
    S. Schmidt
    A. Staebler
    T. Fehm
    F. Fend
    J. Schittenhelm
    D. Wallwiener
    E. Grischke
    Medical Oncology, 2015, 32
  • [35] Validation and comparison of breast graded prognostic assessment score and modified breast graded prognostic assessment in patients with brain metastases as prognostic tool
    Fabregat-Franco, Carles
    Stradella, Agostina
    Navarro, Valentin
    Linares, Jennifer
    Recalde Penabad, Sabela
    Velasco Fargas, Roser
    Simo Parra, Marta
    Fernandez Ortega, Adela
    Vethencourt, Andrea
    Falo Zamora, Catalina
    Vazquez Fernandez, Silvia
    Villanueva Vazquez, Rafael
    Galdeano, Manuel
    Gil-Gil, Miguel
    CANCER RESEARCH, 2020, 80 (04)
  • [36] Comparative Performances of Prognostic Indexes for Breast Cancer Patients Presenting with Brain Metastases.
    Braccini, A-L
    Azria, D.
    Thezenas, S.
    Ferrero, J-M
    Romieu, G.
    Jacot, W.
    CANCER RESEARCH, 2011, 71
  • [37] IS THE BREAST CANCER GRADED PROGNOSTIC ASSESSMENT TOOL VALID IN SCOTTISH PATIENTS WITH SECONDARY BRAIN METASTASES?
    Wells, L. A. R.
    Kerr, G.
    MacLennan, M.
    Evans, T. K. A.
    BREAST, 2013, 22 : S45 - S46
  • [38] Prognostic factors and survival according to tumor subtype in women presenting with breast cancer brain metastases at initial diagnosis
    Leone, J. P.
    Leone, J.
    Zwenger, A. O.
    Iturbe, J.
    Leone, B. A.
    Vallejo, C. T.
    CANCER RESEARCH, 2017, 77
  • [39] Validation of the Graded Prognostic Assessment for Patients with Lung Cancer and Brain Metastases
    Hong, S. W.
    Song, C.
    Jeon, W.
    Kim, J.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S814 - S815
  • [40] Novel graded prognostic assessment for colorectal cancer patients with brain metastases
    Kim, Byoung Hyuck
    Park, Hae Jin
    Kim, Kyubo
    Han, Sae-Won
    Kim, Tae-You
    Jeong, Seung-Yong
    Park, Kyu Joo
    Chie, Eui Kyu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (06) : 1112 - 1120